Rhumbline Advisers Covetrus, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$20.69 - $20.91 $302,405 - $305,620	14,616 Added 4.58%	333,936 $6.97 Million
Q2 2022 Aug 11, 2022	BUY	$13.8 - $20.82 $240,506 - $362,850	17,428 Added 5.77%	319,320 $6.63 Million
Q1 2022 May 12, 2022	SELL	$15.96 - $18.87 $58,956 - $69,705	-3,694 Reduced 1.21%	301,892 $5.07 Million
Q4 2021 Feb 10, 2022	BUY	$16.79 - $20.37 $182,456 - $221,360	10,867 Added 3.69%	305,586 $6.1 Million
Q3 2021 Nov 12, 2021	SELL	$18.14 - $27.03 $594,429 - $885,746	-32,769 Reduced 10.01%	294,719 $5.35 Million
Q2 2021 Aug 05, 2021	SELL	$25.24 - $30.86 $800,436 - $978,663	-31,713 Reduced 8.83%	327,488 $8.84 Million
Q1 2021 May 06, 2021	SELL	$28.29 - $39.89 $39,492 - $55,686	-1,396 Reduced 0.39%	359,201 $10.8 Million
Q4 2020 Feb 10, 2021	BUY	$24.45 - $31.59 $1.37 Million - $1.77 Million	56,034 Added 18.4%	360,597 $10.4 Million
Q3 2020 Nov 12, 2020	SELL	$17.22 - $24.59 $317,278 - $453,070	-18,425 Reduced 5.7%	304,563 $7.43 Million
Q2 2020 Aug 13, 2020	BUY	$6.46 - $19.27 $301,132 - $898,271	46,615 Added 16.87%	322,988 $5.78 Million
Q1 2020 May 06, 2020	BUY	$5.64 - $15.23 $148,692 - $401,523	26,364 Added 10.55%	276,373 $2.25 Million
Q4 2019 Feb 05, 2020	BUY	$8.8 - $14.93 $113,326 - $192,268	12,878 Added 5.43%	250,009 $3.3 Million
Q3 2019 Oct 23, 2019	SELL	$11.76 - $25.57 $8,984 - $19,535	-764 Reduced 0.32%	237,131 $2.82 Million
Q2 2019 Aug 14, 2019	BUY	$22.88 - $33.27 $622,130 - $904,644	27,191 Added 12.9%	237,895 $5.82 Million
Q1 2019 May 01, 2019	BUY	$31.52 - $46.19 $6.64 Million - $9.73 Million	210,704 New	210,704 $6.71 Million

Others Institutions Holding CVET

# of Institutions

Shares Held

72.9K

Call Options Held

Put Options Held

View Full List

About COVETRUS, INC.

Ticker CVET
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 140,123,008
Description
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...

More about CVET

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account